SFM
CINC

Sphera Funds Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Sphera Funds Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-529,640
Closed -$6.51M – 101
2022
Q4 		$6.51M Buy
529,640
+410,690
+345% +$9.79M 1.4% 24
2022
Q3 		$3.9M Buy
+118,950
New +$3.36M 0.54% 44

Sphera Funds Management's CINC Position: Q1 2023 in Review

Sphera Funds Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 529,640 shares — an estimated $6.51M sold.

Sphera Funds Management first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $6.51M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Sphera Funds Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Sphera Funds Management sold 529,640 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $6.51M.
  • Sphera Funds Management first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Sphera Funds Management's CinCor Pharma, Inc. Common Stock position peaked at $6.51M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Sphera Funds Management's 13F filing for Q1 2023, filed 15 May 2023.